#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Roles of Bacterial Virulence Factors During Invasion
1-1	0-2	4.	person[1]	new[1]	_	_
1-2	3-8	Roles	person[1]	new[1]	_	_
1-3	9-11	of	person[1]	new[1]	_	_
1-4	12-21	Bacterial	person[1]|abstract[3]	new[1]|new[3]	coref	3-12[11_3]
1-5	22-31	Virulence	person[1]|abstract|abstract[3]	new[1]|new|new[3]	coref	3-13
1-6	32-39	Factors	person[1]|abstract[3]	new[1]|new[3]	_	_
1-7	40-46	During	person[1]|abstract[3]	new[1]|new[3]	_	_
1-8	47-55	Invasion	person[1]|abstract[3]|event	new[1]|new[3]|new	coref	8-17[38_0]

#Text=Through the Barriers of the CNS
2-1	56-63	Through	_	_	_	_
2-2	64-67	the	object[5]	new[5]	coref	13-26[67_5]
2-3	68-76	Barriers	object[5]	new[5]	_	_
2-4	77-79	of	object[5]	new[5]	_	_
2-5	80-83	the	object[5]|place[6]	new[5]|new[6]	coref	3-6[7_6]
2-6	84-87	CNS	object[5]|place[6]	new[5]|new[6]	_	_

#Text=To be able to enter the CNS , bacterial pathogens use several virulence factors , which are involved in the different steps of pathogenesis .
3-1	88-90	To	_	_	_	_
3-2	91-93	be	_	_	_	_
3-3	94-98	able	_	_	_	_
3-4	99-101	to	_	_	_	_
3-5	102-107	enter	_	_	_	_
3-6	108-111	the	place[7]	giv[7]	coref	23-17[102_7]
3-7	112-115	CNS	place[7]	giv[7]	_	_
3-8	116-117	,	_	_	_	_
3-9	118-127	bacterial	abstract|animal[9]	new|new[9]	coref	8-8[0_9]
3-10	128-137	pathogens	animal[9]	new[9]	_	_
3-11	138-141	use	_	_	_	_
3-12	142-149	several	abstract[11]	giv[11]	coref	9-8[48_11]
3-13	150-159	virulence	abstract|abstract[11]	giv|giv[11]	coref	9-9
3-14	160-167	factors	abstract[11]	giv[11]	_	_
3-15	168-169	,	_	_	_	_
3-16	170-175	which	_	_	_	_
3-17	176-179	are	_	_	_	_
3-18	180-188	involved	_	_	_	_
3-19	189-191	in	_	_	_	_
3-20	192-195	the	abstract[12]	new[12]	_	_
3-21	196-205	different	abstract[12]	new[12]	_	_
3-22	206-211	steps	abstract[12]	new[12]	_	_
3-23	212-214	of	abstract[12]	new[12]	_	_
3-24	215-227	pathogenesis	abstract[12]|abstract	new[12]|new	_	_
3-25	228-229	.	_	_	_	_

#Text=Of major importance is the capsule of both gram-positive and gram-negative bacteria .
4-1	230-232	Of	_	_	_	_
4-2	233-238	major	abstract[14]	new[14]	_	_
4-3	239-249	importance	abstract[14]	new[14]	_	_
4-4	250-252	is	_	_	_	_
4-5	253-256	the	object[15]	new[15]	coref	8-4[33_15]
4-6	257-264	capsule	object[15]	new[15]	_	_
4-7	265-267	of	object[15]	new[15]	_	_
4-8	268-272	both	object[15]|animal[16]	new[15]|new[16]	coref	9-14[49_16]
4-9	273-286	gram-positive	object[15]|animal[16]	new[15]|new[16]	_	_
4-10	287-290	and	object[15]|animal[16]	new[15]|new[16]	_	_
4-11	291-304	gram-negative	object[15]|animal[16]	new[15]|new[16]	_	_
4-12	305-313	bacteria	object[15]|animal[16]	new[15]|new[16]	_	_
4-13	314-315	.	_	_	_	_

#Text=The capsular polysaccharide has a protective function in bloodstream survival .
5-1	316-319	The	substance[18]	new[18]	_	_
5-2	320-328	capsular	abstract|substance[18]	new|new[18]	_	_
5-3	329-343	polysaccharide	substance[18]	new[18]	_	_
5-4	344-347	has	_	_	_	_
5-5	348-349	a	abstract[19]	new[19]	ana	6-3[0_19]
5-6	350-360	protective	abstract[19]	new[19]	_	_
5-7	361-369	function	abstract[19]	new[19]	_	_
5-8	370-372	in	abstract[19]	new[19]	_	_
5-9	373-384	bloodstream	abstract[19]|abstract|event[21]	new[19]|new|new[21]	ana	7-1[0_21]
5-10	385-393	survival	abstract[19]|event[21]	new[19]|new[21]	_	_
5-11	394-395	.	_	_	_	_

#Text=However , it was observed to attenuate invasion of the BBB and BCSFB .
6-1	396-403	However	_	_	_	_
6-2	404-405	,	_	_	_	_
6-3	406-408	it	abstract	giv	_	_
6-4	409-412	was	_	_	_	_
6-5	413-421	observed	_	_	_	_
6-6	422-424	to	_	_	_	_
6-7	425-434	attenuate	_	_	_	_
6-8	435-443	invasion	abstract[23]	new[23]	_	_
6-9	444-446	of	abstract[23]	new[23]	_	_
6-10	447-450	the	abstract[23]|organization[24]|object[25]	new[23]|new[24]|new[25]	coref|coref	20-13[85_24]|20-13[86_25]
6-11	451-454	BBB	abstract[23]|organization[24]|object[25]	new[23]|new[24]|new[25]	_	_
6-12	455-458	and	abstract[23]|object[25]	new[23]|new[25]	_	_
6-13	459-464	BCSFB	abstract[23]|object[25]|object	new[23]|new[25]|new	coref	20-16
6-14	465-466	.	_	_	_	_

#Text=This could result from electrostatic repulsion or from the masking of bacterial surface structures .
7-1	467-471	This	event	giv	coref	8-7[35_0]
7-2	472-477	could	_	_	_	_
7-3	478-484	result	abstract	new	none|none	7-3[0_194]|32-14
7-4	485-489	from	_	_	_	_
7-5	490-503	electrostatic	abstract[28]	new[28]	_	_
7-6	504-513	repulsion	abstract[28]	new[28]	_	_
7-7	514-516	or	_	_	_	_
7-8	517-521	from	_	_	_	_
7-9	522-525	the	abstract[29]	new[29]	_	_
7-10	526-533	masking	abstract[29]	new[29]	_	_
7-11	534-536	of	abstract[29]	new[29]	_	_
7-12	537-546	bacterial	abstract[29]|object[31]	new[29]|new[31]	_	_
7-13	547-554	surface	abstract[29]|place|object[31]	new[29]|new|new[31]	_	_
7-14	555-565	structures	abstract[29]|object[31]	new[29]|new[31]	_	_
7-15	566-567	.	_	_	_	_

#Text=The necessity of the capsule for the pathogens survival in the blood but simultaneous hindrance of invasion of the host ’s tissues indicates a need for the regulation of capsule expression .
8-1	568-571	The	abstract[32]	new[32]	_	_
8-2	572-581	necessity	abstract[32]	new[32]	_	_
8-3	582-584	of	abstract[32]	new[32]	_	_
8-4	585-588	the	abstract[32]|object[33]	new[32]|giv[33]	coref	8-30[0_33]
8-5	589-596	capsule	abstract[32]|object[33]	new[32]|giv[33]	_	_
8-6	597-600	for	abstract[32]|object[33]	new[32]|giv[33]	_	_
8-7	601-604	the	abstract[32]|object[33]|event[35]	new[32]|giv[33]|giv[35]	_	_
8-8	605-614	pathogens	abstract[32]|object[33]|animal|event[35]	new[32]|giv[33]|giv|giv[35]	_	_
8-9	615-623	survival	abstract[32]|object[33]|event[35]	new[32]|giv[33]|giv[35]	_	_
8-10	624-626	in	abstract[32]|object[33]|event[35]	new[32]|giv[33]|giv[35]	_	_
8-11	627-630	the	abstract[32]|object[33]|event[35]|substance[36]	new[32]|giv[33]|giv[35]|new[36]	coref	13-23[65_36]
8-12	631-636	blood	abstract[32]|object[33]|event[35]|substance[36]	new[32]|giv[33]|giv[35]|new[36]	_	_
8-13	637-640	but	_	_	_	_
8-14	641-653	simultaneous	abstract[37]	new[37]	_	_
8-15	654-663	hindrance	abstract[37]	new[37]	_	_
8-16	664-666	of	abstract[37]	new[37]	_	_
8-17	667-675	invasion	abstract[37]|event[38]	new[37]|giv[38]	coref	26-4[0_38]
8-18	676-678	of	abstract[37]|event[38]	new[37]|giv[38]	_	_
8-19	679-682	the	abstract[37]|event[38]|object[40]	new[37]|giv[38]|new[40]	_	_
8-20	683-687	host	abstract[37]|event[38]|person[39]|object[40]	new[37]|giv[38]|new[39]|new[40]	coref	21-9[91_39]
8-21	688-690	’s	abstract[37]|event[38]|person[39]|object[40]	new[37]|giv[38]|new[39]|new[40]	_	_
8-22	691-698	tissues	abstract[37]|event[38]|object[40]	new[37]|giv[38]|new[40]	_	_
8-23	699-708	indicates	_	_	_	_
8-24	709-710	a	abstract[41]	new[41]	_	_
8-25	711-715	need	abstract[41]	new[41]	_	_
8-26	716-719	for	abstract[41]	new[41]	_	_
8-27	720-723	the	abstract[41]|abstract[42]	new[41]|new[42]	_	_
8-28	724-734	regulation	abstract[41]|abstract[42]	new[41]|new[42]	_	_
8-29	735-737	of	abstract[41]|abstract[42]	new[41]|new[42]	_	_
8-30	738-745	capsule	abstract[41]|abstract[42]|object|abstract[44]	new[41]|new[42]|giv|new[44]	coref	9-2[45_0]
8-31	746-756	expression	abstract[41]|abstract[42]|abstract[44]	new[41]|new[42]|new[44]	_	_
8-32	757-758	.	_	_	_	_

#Text=Besides the capsule , a multitude of further virulence factors are used by gram-positive and gram-negative bacteria .
9-1	759-766	Besides	_	_	_	_
9-2	767-770	the	object[45]	giv[45]	_	_
9-3	771-778	capsule	object[45]	giv[45]	_	_
9-4	779-780	,	_	_	_	_
9-5	781-782	a	abstract[46]	new[46]	_	_
9-6	783-792	multitude	abstract[46]	new[46]	_	_
9-7	793-795	of	abstract[46]	new[46]	_	_
9-8	796-803	further	abstract[46]|abstract[48]	new[46]|giv[48]	coref	10-15[0_48]
9-9	804-813	virulence	abstract[46]|abstract|abstract[48]	new[46]|giv|giv[48]	coref	13-10
9-10	814-821	factors	abstract[46]|abstract[48]	new[46]|giv[48]	_	_
9-11	822-825	are	_	_	_	_
9-12	826-830	used	_	_	_	_
9-13	831-833	by	_	_	_	_
9-14	834-847	gram-positive	animal[49]	giv[49]	coref	14-8[71_49]
9-15	848-851	and	animal[49]	giv[49]	_	_
9-16	852-865	gram-negative	animal[49]	giv[49]	_	_
9-17	866-874	bacteria	animal[49]	giv[49]	_	_
9-18	875-876	.	_	_	_	_

#Text=These include , among others , adhesins and internalins , pore-forming toxins , and factors involved in intracellular movement as well as cell-to cell spread and are summarized in
10-1	877-882	These	_	_	_	_
10-2	883-890	include	_	_	_	_
10-3	891-892	,	_	_	_	_
10-4	893-898	among	_	_	_	_
10-5	899-905	others	_	_	_	_
10-6	906-907	,	_	_	_	_
10-7	908-916	adhesins	abstract	new	_	_
10-8	917-920	and	_	_	_	_
10-9	921-932	internalins	substance	new	coref	28-10[143_0]
10-10	933-934	,	_	_	_	_
10-11	935-947	pore-forming	substance[52]	new[52]	_	_
10-12	948-954	toxins	substance[52]	new[52]	_	_
10-13	955-956	,	_	_	_	_
10-14	957-960	and	_	_	_	_
10-15	961-968	factors	abstract	giv	coref	13-8[60_0]
10-16	969-977	involved	_	_	_	_
10-17	978-980	in	_	_	_	_
10-18	981-994	intracellular	abstract[54]	new[54]	_	_
10-19	995-1003	movement	abstract[54]	new[54]	_	_
10-20	1004-1006	as	_	_	_	_
10-21	1007-1011	well	_	_	_	_
10-22	1012-1014	as	_	_	_	_
10-23	1015-1022	cell-to	place[55]	new[55]	_	_
10-24	1023-1027	cell	place[55]	new[55]	_	_
10-25	1028-1034	spread	_	_	_	_
10-26	1035-1038	and	_	_	_	_
10-27	1039-1042	are	_	_	_	_
10-28	1043-1053	summarized	_	_	_	_
10-29	1054-1056	in	_	_	_	_

#Text=Figure 2
11-1	1057-1063	Figure	abstract[56]	new[56]	_	_
11-2	1064-1065	2	abstract[56]	new[56]	_	_

#Text=.
12-1	1066-1067	.	_	_	_	_

#Text=In this review , we will focus particularly on virulence factors , for which evidence for an involvement during brain entry across the blood – brain barriers has been proposed .
13-1	1068-1070	In	_	_	_	_
13-2	1071-1075	this	abstract[57]	new[57]	_	_
13-3	1076-1082	review	abstract[57]	new[57]	_	_
13-4	1083-1084	,	_	_	_	_
13-5	1085-1087	we	person	acc	_	_
13-6	1088-1092	will	_	_	_	_
13-7	1093-1098	focus	_	_	_	_
13-8	1099-1111	particularly	abstract[60]	giv[60]	coref	14-4[70_60]
13-9	1112-1114	on	abstract[60]	giv[60]	_	_
13-10	1115-1124	virulence	abstract|abstract[60]	giv|giv[60]	coref	14-5
13-11	1125-1132	factors	abstract[60]	giv[60]	_	_
13-12	1133-1134	,	_	_	_	_
13-13	1135-1138	for	_	_	_	_
13-14	1139-1144	which	abstract[61]	new[61]	_	_
13-15	1145-1153	evidence	abstract[61]	new[61]	_	_
13-16	1154-1157	for	abstract[61]	new[61]	_	_
13-17	1158-1160	an	abstract[61]|abstract[62]	new[61]|new[62]	coref	32-24[183_62]
13-18	1161-1172	involvement	abstract[61]|abstract[62]	new[61]|new[62]	_	_
13-19	1173-1179	during	abstract[61]|abstract[62]	new[61]|new[62]	_	_
13-20	1180-1185	brain	abstract[61]|abstract[62]|object|place[64]	new[61]|new[62]|new|new[64]	coref|coref	13-26|31-21[173_64]
13-21	1186-1191	entry	abstract[61]|abstract[62]|place[64]	new[61]|new[62]|new[64]	_	_
13-22	1192-1198	across	abstract[61]|abstract[62]|place[64]	new[61]|new[62]|new[64]	_	_
13-23	1199-1202	the	abstract[61]|abstract[62]|place[64]|substance[65]	new[61]|new[62]|new[64]|giv[65]	coref	22-25[0_65]
13-24	1203-1208	blood	abstract[61]|abstract[62]|place[64]|substance[65]	new[61]|new[62]|new[64]|giv[65]	_	_
13-25	1209-1210	–	_	_	_	_
13-26	1211-1216	brain	object|object[67]	giv|giv[67]	coref|coref	20-4[83_67]|20-10[84_0]
13-27	1217-1225	barriers	object[67]	giv[67]	_	_
13-28	1226-1229	has	_	_	_	_
13-29	1230-1234	been	_	_	_	_
13-30	1235-1243	proposed	_	_	_	_
13-31	1244-1245	.	_	_	_	_

#Text=A summary of these virulence factors for gram-positive and gram-negative bacteria is given in Table 1 at the end of this section .
14-1	1246-1247	A	abstract[68]	new[68]	_	_
14-2	1248-1255	summary	abstract[68]	new[68]	_	_
14-3	1256-1258	of	abstract[68]	new[68]	_	_
14-4	1259-1264	these	abstract[68]|abstract[70]	new[68]|giv[70]	_	_
14-5	1265-1274	virulence	abstract[68]|abstract|abstract[70]	new[68]|giv|giv[70]	_	_
14-6	1275-1282	factors	abstract[68]|abstract[70]	new[68]|giv[70]	_	_
14-7	1283-1286	for	abstract[68]|abstract[70]	new[68]|giv[70]	_	_
14-8	1287-1300	gram-positive	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
14-9	1301-1304	and	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
14-10	1305-1318	gram-negative	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
14-11	1319-1327	bacteria	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
14-12	1328-1330	is	_	_	_	_
14-13	1331-1336	given	_	_	_	_
14-14	1337-1339	in	_	_	_	_
14-15	1340-1345	Table	object[72]	new[72]	_	_
14-16	1346-1347	1	object[72]	new[72]	_	_
14-17	1348-1350	at	_	_	_	_
14-18	1351-1354	the	abstract[73]	new[73]	_	_
14-19	1355-1358	end	abstract[73]	new[73]	_	_
14-20	1359-1361	of	abstract[73]	new[73]	_	_
14-21	1362-1366	this	abstract[73]|abstract[74]	new[73]|new[74]	_	_
14-22	1367-1374	section	abstract[73]|abstract[74]	new[73]|new[74]	_	_
14-23	1375-1376	.	_	_	_	_

#Text=4.1 .
15-1	1377-1380	4.1	abstract	new	_	_
15-2	1381-1382	.	_	_	_	_

#Text=Gram-Positive Bacteria
16-1	1383-1396	Gram-Positive	substance[76]	new[76]	_	_
16-2	1397-1405	Bacteria	substance[76]	new[76]	_	_

#Text=4.1.1 .
17-1	1406-1411	4.1.1	abstract	new	_	_
17-2	1412-1413	.	_	_	_	_

#Text=Listeria Monocytogenes
18-1	1414-1422	Listeria	person|abstract[79]	new|new[79]	coref	19-1[80_79]
18-2	1423-1436	Monocytogenes	abstract[79]	new[79]	_	_

#Text=Listeria monocytogenes ( L. monocytogenes ) is a facultative intracellular gram-positive bacterium .
19-1	1437-1445	Listeria	animal[80]	giv[80]	coref	19-8[81_80]
19-2	1446-1459	monocytogenes	animal[80]	giv[80]	_	_
19-3	1460-1461	(	_	_	_	_
19-4	1462-1464	L.	_	_	_	_
19-5	1465-1478	monocytogenes	_	_	_	_
19-6	1479-1480	)	_	_	_	_
19-7	1481-1483	is	_	_	_	_
19-8	1484-1485	a	animal[81]	giv[81]	ana	20-1[0_81]
19-9	1486-1497	facultative	animal[81]	giv[81]	_	_
19-10	1498-1511	intracellular	animal[81]	giv[81]	_	_
19-11	1512-1525	gram-positive	animal[81]	giv[81]	_	_
19-12	1526-1535	bacterium	animal[81]	giv[81]	_	_
19-13	1536-1537	.	_	_	_	_

#Text=It can traverse several physiological barriers and finally enter the brain via the BBB or BCSFB , especially in immunocompromised individuals .
20-1	1538-1540	It	animal	giv	ana	21-1
20-2	1541-1544	can	_	_	_	_
20-3	1545-1553	traverse	abstract	new	none|none	20-3|22-6
20-4	1554-1561	several	object[83]	giv[83]	_	_
20-5	1562-1575	physiological	object[83]	giv[83]	_	_
20-6	1576-1584	barriers	object[83]	giv[83]	_	_
20-7	1585-1588	and	_	_	_	_
20-8	1589-1596	finally	_	_	_	_
20-9	1597-1602	enter	_	_	_	_
20-10	1603-1606	the	object[84]	giv[84]	coref	23-23[104_84]
20-11	1607-1612	brain	object[84]	giv[84]	_	_
20-12	1613-1616	via	object[84]	giv[84]	_	_
20-13	1617-1620	the	object[84]|object[85]|object[86]	giv[84]|giv[85]|giv[86]	coref|coref	24-7[106_85]|28-16[146_86]
20-14	1621-1624	BBB	object[84]|object[85]|object[86]	giv[84]|giv[85]|giv[86]	_	_
20-15	1625-1627	or	object[84]|object[86]	giv[84]|giv[86]	_	_
20-16	1628-1633	BCSFB	object[84]|object[86]|object	giv[84]|giv[86]|giv	coref	24-10[107_0]
20-17	1634-1635	,	_	_	_	_
20-18	1636-1646	especially	person[88]	new[88]	_	_
20-19	1647-1649	in	person[88]	new[88]	_	_
20-20	1650-1667	immunocompromised	person[88]	new[88]	_	_
20-21	1668-1679	individuals	person[88]	new[88]	_	_
20-22	1680-1681	.	_	_	_	_

#Text=It is ingested through highly contaminated food by the host .
21-1	1682-1684	It	animal	giv	coref	22-4[92_0]
21-2	1685-1687	is	_	_	_	_
21-3	1688-1696	ingested	_	_	_	_
21-4	1697-1704	through	_	_	_	_
21-5	1705-1711	highly	substance[90]	new[90]	_	_
21-6	1712-1724	contaminated	substance[90]	new[90]	_	_
21-7	1725-1729	food	substance[90]	new[90]	_	_
21-8	1730-1732	by	substance[90]	new[90]	_	_
21-9	1733-1736	the	substance[90]|person[91]	new[90]|giv[91]	coref	25-10[118_91]
21-10	1737-1741	host	substance[90]|person[91]	new[90]|giv[91]	_	_
21-11	1742-1743	.	_	_	_	_

#Text=Once ingested , L. monocytogenes traverses the intestinal epithelial barrier into the lamina propria followed by dissemination of the pathogen via the lymph and blood .
22-1	1744-1748	Once	_	_	_	_
22-2	1749-1757	ingested	_	_	_	_
22-3	1758-1759	,	_	_	_	_
22-4	1760-1762	L.	animal[92]	giv[92]	coref	23-1[98_92]
22-5	1763-1776	monocytogenes	animal[92]	giv[92]	_	_
22-6	1777-1786	traverses	abstract	new	coref	32-27[185_0]
22-7	1787-1790	the	object[93]	new[93]	_	_
22-8	1791-1801	intestinal	object[93]	new[93]	_	_
22-9	1802-1812	epithelial	object[93]	new[93]	_	_
22-10	1813-1820	barrier	object[93]	new[93]	_	_
22-11	1821-1825	into	_	_	_	_
22-12	1826-1829	the	_	_	_	_
22-13	1830-1836	lamina	_	_	_	_
22-14	1837-1844	propria	_	_	_	_
22-15	1845-1853	followed	_	_	_	_
22-16	1854-1856	by	_	_	_	_
22-17	1857-1870	dissemination	event[94]	new[94]	_	_
22-18	1871-1873	of	event[94]	new[94]	_	_
22-19	1874-1877	the	event[94]|object[95]	new[94]|new[95]	coref	27-7[139_95]
22-20	1878-1886	pathogen	event[94]|object[95]	new[94]|new[95]	_	_
22-21	1887-1890	via	event[94]|object[95]	new[94]|new[95]	_	_
22-22	1891-1894	the	event[94]|object[95]|person[96]	new[94]|new[95]|new[96]	_	_
22-23	1895-1900	lymph	event[94]|object[95]|person[96]	new[94]|new[95]|new[96]	_	_
22-24	1901-1904	and	event[94]|object[95]	new[94]|new[95]	_	_
22-25	1905-1910	blood	event[94]|object[95]|substance	new[94]|new[95]|giv	_	_
22-26	1911-1912	.	_	_	_	_

#Text=L. monocytogenes has multiple target organs , including the liver and spleen , and can enter the CNS across the barriers of the brain .
23-1	1913-1915	L.	animal[98]	giv[98]	coref	25-1[116_98]
23-2	1916-1929	monocytogenes	animal[98]	giv[98]	_	_
23-3	1930-1933	has	_	_	_	_
23-4	1934-1942	multiple	abstract[99]	new[99]	_	_
23-5	1943-1949	target	abstract[99]	new[99]	_	_
23-6	1950-1956	organs	abstract[99]	new[99]	_	_
23-7	1957-1958	,	abstract[99]	new[99]	_	_
23-8	1959-1968	including	abstract[99]	new[99]	_	_
23-9	1969-1972	the	abstract[99]|object[100]	new[99]|new[100]	_	_
23-10	1973-1978	liver	abstract[99]|object[100]	new[99]|new[100]	_	_
23-11	1979-1982	and	abstract[99]	new[99]	_	_
23-12	1983-1989	spleen	abstract[99]|place	new[99]|new	_	_
23-13	1990-1991	,	_	_	_	_
23-14	1992-1995	and	_	_	_	_
23-15	1996-1999	can	_	_	_	_
23-16	2000-2005	enter	_	_	_	_
23-17	2006-2009	the	place[102]	giv[102]	_	_
23-18	2010-2013	CNS	place[102]	giv[102]	_	_
23-19	2014-2020	across	place[102]	giv[102]	_	_
23-20	2021-2024	the	place[102]|place[103]	giv[102]|new[103]	_	_
23-21	2025-2033	barriers	place[102]|place[103]	giv[102]|new[103]	_	_
23-22	2034-2036	of	place[102]|place[103]	giv[102]|new[103]	_	_
23-23	2037-2040	the	place[102]|place[103]|object[104]	giv[102]|new[103]|giv[104]	coref	29-29[158_104]
23-24	2041-2046	brain	place[102]|place[103]|object[104]	giv[102]|new[103]|giv[104]	_	_
23-25	2047-2048	.	_	_	_	_

#Text=In addition to direct traversal of the BBB and BCSFB via the transcellular route , transportation across the BBB within leukocytes and retrograde migration within axons of cranial nerves have been described .
24-1	2049-2051	In	_	_	_	_
24-2	2052-2060	addition	_	_	_	_
24-3	2061-2063	to	_	_	_	_
24-4	2064-2070	direct	event[105]	new[105]	_	_
24-5	2071-2080	traversal	event[105]	new[105]	_	_
24-6	2081-2083	of	event[105]	new[105]	_	_
24-7	2084-2087	the	event[105]|organization[106]	new[105]|giv[106]	coref	24-18[110_106]
24-8	2088-2091	BBB	event[105]|organization[106]	new[105]|giv[106]	_	_
24-9	2092-2095	and	event[105]	new[105]	_	_
24-10	2096-2101	BCSFB	event[105]|object[107]	new[105]|giv[107]	coref	28-19[0_107]
24-11	2102-2105	via	event[105]|object[107]	new[105]|giv[107]	_	_
24-12	2106-2109	the	event[105]|object[107]|abstract[108]	new[105]|giv[107]|new[108]	_	_
24-13	2110-2123	transcellular	event[105]|object[107]|abstract[108]	new[105]|giv[107]|new[108]	_	_
24-14	2124-2129	route	event[105]|object[107]|abstract[108]	new[105]|giv[107]|new[108]	_	_
24-15	2130-2131	,	_	_	_	_
24-16	2132-2146	transportation	abstract[109]	new[109]	_	_
24-17	2147-2153	across	abstract[109]	new[109]	_	_
24-18	2154-2157	the	abstract[109]|organization[110]	new[109]|giv[110]	coref	28-16[145_110]
24-19	2158-2161	BBB	abstract[109]|organization[110]	new[109]|giv[110]	_	_
24-20	2162-2168	within	abstract[109]|organization[110]	new[109]|giv[110]	_	_
24-21	2169-2179	leukocytes	abstract[109]|organization[110]|place	new[109]|giv[110]|new	_	_
24-22	2180-2183	and	abstract[109]|organization[110]	new[109]|giv[110]	_	_
24-23	2184-2194	retrograde	abstract[109]|organization[110]|event[112]	new[109]|giv[110]|new[112]	_	_
24-24	2195-2204	migration	abstract[109]|organization[110]|event[112]	new[109]|giv[110]|new[112]	_	_
24-25	2205-2211	within	abstract[109]|organization[110]|event[112]	new[109]|giv[110]|new[112]	_	_
24-26	2212-2217	axons	abstract[109]|organization[110]|event[112]|object[113]	new[109]|giv[110]|new[112]|new[113]	_	_
24-27	2218-2220	of	abstract[109]|organization[110]|event[112]|object[113]	new[109]|giv[110]|new[112]|new[113]	_	_
24-28	2221-2228	cranial	abstract[109]|organization[110]|event[112]|object[113]|object[114]	new[109]|giv[110]|new[112]|new[113]|new[114]	_	_
24-29	2229-2235	nerves	abstract[109]|organization[110]|event[112]|object[113]|object[114]	new[109]|giv[110]|new[112]|new[113]|new[114]	_	_
24-30	2236-2240	have	_	_	_	_
24-31	2241-2245	been	_	_	_	_
24-32	2246-2255	described	_	_	_	_
24-33	2256-2257	.	_	_	_	_

#Text=L. monocytogenes can enter non-phagocytotic cells by hijacking the host ’s receptor-mediated endocytosis machinery using the zipper mechanism .
25-1	2258-2260	L.	person|animal[116]	new|giv[116]	coref|coref	26-7|26-7[126_116]
25-2	2261-2274	monocytogenes	animal[116]	giv[116]	_	_
25-3	2275-2278	can	_	_	_	_
25-4	2279-2284	enter	_	_	_	_
25-5	2285-2301	non-phagocytotic	place[117]	new[117]	coref	31-10[169_117]
25-6	2302-2307	cells	place[117]	new[117]	_	_
25-7	2308-2310	by	_	_	_	_
25-8	2311-2320	hijacking	_	_	_	_
25-9	2321-2324	the	abstract[120]	new[120]	coref	33-16[192_120]
25-10	2325-2329	host	person[118]|abstract[120]	giv[118]|new[120]	_	_
25-11	2330-2332	’s	person[118]|abstract[120]	giv[118]|new[120]	_	_
25-12	2333-2350	receptor-mediated	abstract[120]	new[120]	_	_
25-13	2351-2362	endocytosis	abstract|abstract[120]	new|new[120]	coref	27-4[138_0]
25-14	2363-2372	machinery	abstract[120]	new[120]	_	_
25-15	2373-2378	using	_	_	_	_
25-16	2379-2382	the	abstract[122]	new[122]	coref	44-1[271_122]
25-17	2383-2389	zipper	person|abstract[122]	new|new[122]	_	_
25-18	2390-2399	mechanism	abstract[122]	new[122]	_	_
25-19	2400-2401	.	_	_	_	_

#Text=The two major invasion proteins of L. monocytogenes are internalin ( InlA ) and InlB , which bind to eukaryotic cell membrane members E-cadherin and tyrosine kinase receptor protein Met , respectively .
26-1	2402-2405	The	abstract[124]	new[124]	coref	26-10[0_124]
26-2	2406-2409	two	abstract[124]	new[124]	_	_
26-3	2410-2415	major	abstract[124]	new[124]	_	_
26-4	2416-2424	invasion	abstract|abstract[124]	giv|new[124]	_	_
26-5	2425-2433	proteins	abstract[124]	new[124]	_	_
26-6	2434-2436	of	abstract[124]	new[124]	_	_
26-7	2437-2439	L.	abstract[124]|person|animal[126]	new[124]|giv|giv[126]	coref|coref	28-1|28-1[141_126]
26-8	2440-2453	monocytogenes	abstract[124]|animal[126]	new[124]|giv[126]	_	_
26-9	2454-2457	are	_	_	_	_
26-10	2458-2468	internalin	abstract	giv	appos	26-12
26-11	2469-2470	(	_	_	_	_
26-12	2471-2475	InlA	abstract	giv	_	_
26-13	2476-2477	)	_	_	_	_
26-14	2478-2481	and	_	_	_	_
26-15	2482-2486	InlB	plant	new	_	_
26-16	2487-2488	,	_	_	_	_
26-17	2489-2494	which	_	_	_	_
26-18	2495-2499	bind	_	_	_	_
26-19	2500-2502	to	_	_	_	_
26-20	2503-2513	eukaryotic	person[131]	new[131]	_	_
26-21	2514-2518	cell	person[131]	new[131]	_	_
26-22	2519-2527	membrane	place|person[131]	new|new[131]	coref	41-29
26-23	2528-2535	members	person[131]	new[131]	_	_
26-24	2536-2546	E-cadherin	object	new	coref	33-8
26-25	2547-2550	and	_	_	_	_
26-26	2551-2559	tyrosine	abstract|substance[136]	new|new[136]	coref	29-13[0_136]
26-27	2560-2566	kinase	object|substance[136]	new|new[136]	coref	45-9[279_0]
26-28	2567-2575	receptor	substance|substance[136]	new|new[136]	_	_
26-29	2576-2583	protein	substance[136]	new[136]	_	_
26-30	2584-2587	Met	_	_	_	_
26-31	2588-2589	,	_	_	_	_
26-32	2590-2602	respectively	_	_	_	_
26-33	2603-2604	.	_	_	_	_

#Text=These interactions induce receptor-mediated endocytosis of the pathogen .
27-1	2605-2610	These	event[137]	new[137]	_	_
27-2	2611-2623	interactions	event[137]	new[137]	_	_
27-3	2624-2630	induce	_	_	_	_
27-4	2631-2648	receptor-mediated	abstract[138]	giv[138]	coref	33-18[0_138]
27-5	2649-2660	endocytosis	abstract[138]	giv[138]	_	_
27-6	2661-2663	of	abstract[138]	giv[138]	_	_
27-7	2664-2667	the	abstract[138]|object[139]	giv[138]|giv[139]	coref	35-25[0_139]
27-8	2668-2676	pathogen	abstract[138]|object[139]	giv[138]|giv[139]	_	_
27-9	2677-2678	.	_	_	_	_

#Text=L. monocytogenes has been demonstrated to use one or both internalins to mediate invasion of the BBB and BCSFB .
28-1	2679-2681	L.	person|animal[141]	giv|giv[141]	coref|coref	30-11|30-11[164_141]
28-2	2682-2695	monocytogenes	animal[141]	giv[141]	_	_
28-3	2696-2699	has	_	_	_	_
28-4	2700-2704	been	_	_	_	_
28-5	2705-2717	demonstrated	_	_	_	_
28-6	2718-2720	to	_	_	_	_
28-7	2721-2724	use	_	_	_	_
28-8	2725-2728	one	abstract	new	_	_
28-9	2729-2731	or	_	_	_	_
28-10	2732-2736	both	substance[143]	giv[143]	_	_
28-11	2737-2748	internalins	substance[143]	giv[143]	_	_
28-12	2749-2751	to	_	_	_	_
28-13	2752-2759	mediate	_	_	_	_
28-14	2760-2768	invasion	event[144]	new[144]	_	_
28-15	2769-2771	of	event[144]	new[144]	_	_
28-16	2772-2775	the	event[144]|object[145]|object[146]	new[144]|giv[145]|giv[146]	_	_
28-17	2776-2779	BBB	event[144]|object[145]|object[146]	new[144]|giv[145]|giv[146]	_	_
28-18	2780-2783	and	event[144]|object[146]	new[144]|giv[146]	_	_
28-19	2784-2789	BCSFB	event[144]|object[146]|object	new[144]|giv[146]|giv	coref	31-6[166_0]
28-20	2790-2791	.	_	_	_	_

#Text=A recent study has further demonstrated the importance of the bacterial surface protein InlF , showing that interaction with surface vimentin was required for an optimal colonialization of the brain .
29-1	2792-2793	A	abstract[148]	new[148]	coref	36-3[207_148]
29-2	2794-2800	recent	abstract[148]	new[148]	_	_
29-3	2801-2806	study	abstract[148]	new[148]	_	_
29-4	2807-2810	has	_	_	_	_
29-5	2811-2818	further	_	_	_	_
29-6	2819-2831	demonstrated	_	_	_	_
29-7	2832-2835	the	abstract[149]	new[149]	_	_
29-8	2836-2846	importance	abstract[149]	new[149]	_	_
29-9	2847-2849	of	abstract[149]	new[149]	_	_
29-10	2850-2853	the	abstract[149]|abstract[153]	new[149]|new[153]	_	_
29-11	2854-2863	bacterial	abstract[149]|substance|abstract[153]	new[149]|new|new[153]	coref	32-17
29-12	2864-2871	surface	abstract[149]|place|abstract[153]	new[149]|new|new[153]	coref	29-20
29-13	2872-2879	protein	abstract[149]|substance|abstract[153]	new[149]|giv|new[153]	_	_
29-14	2880-2884	InlF	abstract[149]|abstract[153]	new[149]|new[153]	_	_
29-15	2885-2886	,	_	_	_	_
29-16	2887-2894	showing	_	_	_	_
29-17	2895-2899	that	abstract[154]	new[154]	_	_
29-18	2900-2911	interaction	abstract[154]	new[154]	_	_
29-19	2912-2916	with	abstract[154]	new[154]	_	_
29-20	2917-2924	surface	abstract[154]|place|substance[156]	new[154]|giv|new[156]	_	_
29-21	2925-2933	vimentin	abstract[154]|substance[156]	new[154]|new[156]	_	_
29-22	2934-2937	was	_	_	_	_
29-23	2938-2946	required	_	_	_	_
29-24	2947-2950	for	_	_	_	_
29-25	2951-2953	an	abstract[157]	new[157]	_	_
29-26	2954-2961	optimal	abstract[157]	new[157]	_	_
29-27	2962-2977	colonialization	abstract[157]	new[157]	_	_
29-28	2978-2980	of	abstract[157]	new[157]	_	_
29-29	2981-2984	the	abstract[157]|object[158]	new[157]|giv[158]	_	_
29-30	2985-2990	brain	abstract[157]|object[158]	new[157]|giv[158]	_	_
29-31	2991-2992	.	_	_	_	_

#Text=The MAPK signaling cascade is activated during the invasion of L. monocytogenes .
30-1	2993-2996	The	abstract[161]	new[161]	_	_
30-2	2997-3001	MAPK	abstract|abstract[161]	new|new[161]	coref	31-18
30-3	3002-3011	signaling	abstract|abstract[161]	new|new[161]	coref	38-5
30-4	3012-3019	cascade	abstract[161]	new[161]	_	_
30-5	3020-3022	is	_	_	_	_
30-6	3023-3032	activated	_	_	_	_
30-7	3033-3039	during	_	_	_	_
30-8	3040-3043	the	event[162]	new[162]	coref	32-16[179_162]
30-9	3044-3052	invasion	event[162]	new[162]	_	_
30-10	3053-3055	of	event[162]	new[162]	_	_
30-11	3056-3058	L.	event[162]|person|animal[164]	new[162]|giv|giv[164]	coref|coref	36-20|37-6[218_164]
30-12	3059-3072	monocytogenes	event[162]|animal[164]	new[162]|giv[164]	_	_
30-13	3073-3074	.	_	_	_	_

#Text=In a model system of the BCSFB consisting of choroid plexus epithelial cells , the requirement of MAPK activation for listerial entry was demonstrated .
31-1	3075-3077	In	_	_	_	_
31-2	3078-3079	a	abstract[165]	new[165]	coref	32-20[181_165]
31-3	3080-3085	model	abstract[165]	new[165]	_	_
31-4	3086-3092	system	abstract[165]	new[165]	_	_
31-5	3093-3095	of	abstract[165]	new[165]	_	_
31-6	3096-3099	the	abstract[165]|object[166]	new[165]|giv[166]	coref	32-31[186_166]
31-7	3100-3105	BCSFB	abstract[165]|object[166]	new[165]|giv[166]	_	_
31-8	3106-3116	consisting	_	_	_	_
31-9	3117-3119	of	_	_	_	_
31-10	3120-3127	choroid	object|place[169]	new|giv[169]	coref	36-15[211_169]
31-11	3128-3134	plexus	organization|place[169]	new|giv[169]	_	_
31-12	3135-3145	epithelial	place[169]	giv[169]	_	_
31-13	3146-3151	cells	place[169]	giv[169]	_	_
31-14	3152-3153	,	_	_	_	_
31-15	3154-3157	the	event[170]	new[170]	_	_
31-16	3158-3169	requirement	event[170]	new[170]	_	_
31-17	3170-3172	of	event[170]	new[170]	_	_
31-18	3173-3177	MAPK	event[170]|abstract|abstract[172]	new[170]|giv|new[172]	coref|coref	38-1[224_172]|38-23
31-19	3178-3188	activation	event[170]|abstract[172]	new[170]|new[172]	_	_
31-20	3189-3192	for	event[170]|abstract[172]	new[170]|new[172]	_	_
31-21	3193-3202	listerial	event[170]|abstract[172]|place[173]	new[170]|new[172]|giv[173]	coref	35-21[204_173]
31-22	3203-3208	entry	event[170]|abstract[172]|place[173]	new[170]|new[172]|giv[173]	_	_
31-23	3209-3212	was	_	_	_	_
31-24	3213-3225	demonstrated	_	_	_	_
31-25	3226-3227	.	_	_	_	_

#Text=Both extracellular signal-regulated kinases ( ERK ) 1 and 2 and p38 inhibition resulted in decreased bacterial invasion into this model system suggesting their involvement in the pathogens traversal of the BCSFB .
32-1	3228-3232	Both	abstract[174]	new[174]	appos	32-6[0_174]
32-2	3233-3246	extracellular	abstract[174]	new[174]	_	_
32-3	3247-3263	signal-regulated	abstract[174]	new[174]	_	_
32-4	3264-3271	kinases	abstract[174]	new[174]	_	_
32-5	3272-3273	(	_	_	_	_
32-6	3274-3277	ERK	abstract	giv	ana	32-24
32-7	3278-3279	)	_	_	_	_
32-8	3280-3281	1	_	_	_	_
32-9	3282-3285	and	_	_	_	_
32-10	3286-3287	2	_	_	_	_
32-11	3288-3291	and	_	_	_	_
32-12	3292-3295	p38	abstract|abstract[177]	new|new[177]	_	_
32-13	3296-3306	inhibition	abstract[177]	new[177]	_	_
32-14	3307-3315	resulted	abstract	new	coref	34-3[194_0]
32-15	3316-3318	in	_	_	_	_
32-16	3319-3328	decreased	event[179]	giv[179]	coref	36-20[213_179]
32-17	3329-3338	bacterial	animal|event[179]	giv|giv[179]	_	_
32-18	3339-3347	invasion	event[179]	giv[179]	_	_
32-19	3348-3352	into	event[179]	giv[179]	_	_
32-20	3353-3357	this	event[179]|abstract[181]	giv[179]|giv[181]	_	_
32-21	3358-3363	model	event[179]|person|abstract[181]	giv[179]|new|giv[181]	_	_
32-22	3364-3370	system	event[179]|abstract[181]	giv[179]|giv[181]	_	_
32-23	3371-3381	suggesting	_	_	_	_
32-24	3382-3387	their	abstract|abstract[183]	giv|giv[183]	_	_
32-25	3388-3399	involvement	abstract[183]	giv[183]	_	_
32-26	3400-3402	in	abstract[183]	giv[183]	_	_
32-27	3403-3406	the	abstract[183]|abstract[185]	giv[183]|new[185]	ana	33-1[0_185]
32-28	3407-3416	pathogens	abstract[183]|substance|abstract[185]	giv[183]|new|new[185]	coref	39-9[237_0]
32-29	3417-3426	traversal	abstract[183]|abstract[185]	giv[183]|new[185]	_	_
32-30	3427-3429	of	abstract[183]|abstract[185]	giv[183]|new[185]	_	_
32-31	3430-3433	the	abstract[183]|abstract[185]|object[186]	giv[183]|new[185]|giv[186]	coref	36-11[209_186]
32-32	3434-3439	BCSFB	abstract[183]|abstract[185]|object[186]	giv[183]|new[185]|giv[186]	_	_
32-33	3440-3441	.	_	_	_	_

#Text=It was previously described that ubiquitination of E-cadherin and Met leads to the recruitment of the clathrin-mediated endocytosis machinery .
33-1	3442-3444	It	abstract	giv	_	_
33-2	3445-3448	was	_	_	_	_
33-3	3449-3459	previously	_	_	_	_
33-4	3460-3469	described	_	_	_	_
33-5	3470-3474	that	_	_	_	_
33-6	3475-3489	ubiquitination	abstract[188]	new[188]	ana	34-1[0_188]
33-7	3490-3492	of	abstract[188]	new[188]	_	_
33-8	3493-3503	E-cadherin	abstract[188]|substance	new[188]|giv	_	_
33-9	3504-3507	and	_	_	_	_
33-10	3508-3511	Met	_	_	_	_
33-11	3512-3517	leads	_	_	_	_
33-12	3518-3520	to	_	_	_	_
33-13	3521-3524	the	event[190]	new[190]	_	_
33-14	3525-3536	recruitment	event[190]	new[190]	_	_
33-15	3537-3539	of	event[190]	new[190]	_	_
33-16	3540-3543	the	event[190]|abstract[192]	new[190]|giv[192]	_	_
33-17	3544-3561	clathrin-mediated	event[190]|abstract[192]	new[190]|giv[192]	_	_
33-18	3562-3573	endocytosis	event[190]|abstract|abstract[192]	new[190]|giv|giv[192]	coref	36-27
33-19	3574-3583	machinery	event[190]|abstract[192]	new[190]|giv[192]	_	_
33-20	3584-3585	.	_	_	_	_

#Text=This in turn results in the polymerization of the actin cytoskeleton .
34-1	3586-3590	This	abstract	giv	_	_
34-2	3591-3593	in	_	_	_	_
34-3	3594-3598	turn	abstract[194]	new[194]	_	_
34-4	3599-3606	results	abstract[194]	new[194]	_	_
34-5	3607-3609	in	abstract[194]	new[194]	_	_
34-6	3610-3613	the	abstract[194]|event[195]	new[194]|new[195]	_	_
34-7	3614-3628	polymerization	abstract[194]|event[195]	new[194]|new[195]	_	_
34-8	3629-3631	of	abstract[194]|event[195]	new[194]|new[195]	_	_
34-9	3632-3635	the	abstract[194]|event[195]|object[197]	new[194]|new[195]|new[197]	_	_
34-10	3636-3641	actin	abstract[194]|event[195]|abstract|object[197]	new[194]|new[195]|new|new[197]	coref	35-15
34-11	3642-3654	cytoskeleton	abstract[194]|event[195]|object[197]	new[194]|new[195]|new[197]	_	_
34-12	3655-3656	.	_	_	_	_

#Text=During this process , dynamin recruits several factors that result in two waves of actin rearrangements and subsequently result in the entry of the pathogen inside of vacuoles .
35-1	3657-3663	During	_	_	_	_
35-2	3664-3668	this	abstract[198]	new[198]	_	_
35-3	3669-3676	process	abstract[198]	new[198]	_	_
35-4	3677-3678	,	_	_	_	_
35-5	3679-3686	dynamin	substance	new	_	_
35-6	3687-3695	recruits	_	_	_	_
35-7	3696-3703	several	abstract[200]	new[200]	_	_
35-8	3704-3711	factors	abstract[200]	new[200]	_	_
35-9	3712-3716	that	_	_	_	_
35-10	3717-3723	result	_	_	_	_
35-11	3724-3726	in	_	_	_	_
35-12	3727-3730	two	abstract[201]	new[201]	_	_
35-13	3731-3736	waves	abstract[201]	new[201]	_	_
35-14	3737-3739	of	abstract[201]	new[201]	_	_
35-15	3740-3745	actin	abstract[201]|abstract|abstract[203]	new[201]|giv|new[203]	coref	41-25
35-16	3746-3760	rearrangements	abstract[201]|abstract[203]	new[201]|new[203]	_	_
35-17	3761-3764	and	abstract[201]	new[201]	_	_
35-18	3765-3777	subsequently	abstract[201]	new[201]	_	_
35-19	3778-3784	result	abstract[201]	new[201]	_	_
35-20	3785-3787	in	abstract[201]	new[201]	_	_
35-21	3788-3791	the	abstract[201]|place[204]	new[201]|giv[204]	_	_
35-22	3792-3797	entry	abstract[201]|place[204]	new[201]|giv[204]	_	_
35-23	3798-3800	of	abstract[201]|place[204]	new[201]|giv[204]	_	_
35-24	3801-3804	the	abstract[201]|place[204]	new[201]|giv[204]	_	_
35-25	3805-3813	pathogen	abstract[201]|place[204]|object	new[201]|giv[204]|giv	_	_
35-26	3814-3820	inside	abstract[201]|place[204]	new[201]|giv[204]	_	_
35-27	3821-3823	of	abstract[201]|place[204]	new[201]|giv[204]	_	_
35-28	3824-3832	vacuoles	abstract[201]|place[204]|object	new[201]|giv[204]|new	_	_
35-29	3833-3834	.	_	_	_	_

#Text=Accordingly , an in vitro study using a model of the BCSFB based on HIBCPP cells , revealed that L. monocytogenes invasion is inhibited if dynamin-mediated endocytosis is blocked .
36-1	3835-3846	Accordingly	_	_	_	_
36-2	3847-3848	,	_	_	_	_
36-3	3849-3851	an	abstract[207]	giv[207]	_	_
36-4	3852-3854	in	abstract[207]	giv[207]	_	_
36-5	3855-3860	vitro	abstract[207]	giv[207]	_	_
36-6	3861-3866	study	abstract[207]	giv[207]	_	_
36-7	3867-3872	using	_	_	_	_
36-8	3873-3874	a	object[208]	new[208]	_	_
36-9	3875-3880	model	object[208]	new[208]	_	_
36-10	3881-3883	of	object[208]	new[208]	_	_
36-11	3884-3887	the	object[208]|object[209]	new[208]|giv[209]	_	_
36-12	3888-3893	BCSFB	object[208]|object[209]	new[208]|giv[209]	_	_
36-13	3894-3899	based	_	_	_	_
36-14	3900-3902	on	_	_	_	_
36-15	3903-3909	HIBCPP	substance|place[211]	new|giv[211]	coref	41-9[252_211]
36-16	3910-3915	cells	place[211]	giv[211]	_	_
36-17	3916-3917	,	_	_	_	_
36-18	3918-3926	revealed	_	_	_	_
36-19	3927-3931	that	_	_	_	_
36-20	3932-3934	L.	person|event[213]	giv|giv[213]	coref	37-6
36-21	3935-3948	monocytogenes	event[213]	giv[213]	_	_
36-22	3949-3957	invasion	event[213]	giv[213]	_	_
36-23	3958-3960	is	_	_	_	_
36-24	3961-3970	inhibited	_	_	_	_
36-25	3971-3973	if	_	_	_	_
36-26	3974-3990	dynamin-mediated	_	_	_	_
36-27	3991-4002	endocytosis	abstract	giv	_	_
36-28	4003-4005	is	_	_	_	_
36-29	4006-4013	blocked	_	_	_	_
36-30	4014-4015	.	_	_	_	_

#Text=Another essential virulence factor of L. monocytogenes is the pore-forming cytolysin Listeriolysin O ( LLO ) .
37-1	4016-4023	Another	abstract[216]	new[216]	coref	42-11[264_216]
37-2	4024-4033	essential	abstract[216]	new[216]	_	_
37-3	4034-4043	virulence	abstract|abstract[216]	new|new[216]	coref	42-14
37-4	4044-4050	factor	abstract[216]	new[216]	_	_
37-5	4051-4053	of	abstract[216]	new[216]	_	_
37-6	4054-4056	L.	abstract[216]|person|animal[218]	new[216]|giv|giv[218]	coref|coref	39-5|41-2[249_218]
37-7	4057-4070	monocytogenes	abstract[216]|animal[218]	new[216]|giv[218]	_	_
37-8	4071-4073	is	_	_	_	_
37-9	4074-4077	the	person[220]	new[220]	appos	37-12[222_220]
37-10	4078-4090	pore-forming	object|person[220]	new|new[220]	_	_
37-11	4091-4100	cytolysin	person[220]	new[220]	_	_
37-12	4101-4114	Listeriolysin	place|person[222]	new|giv[222]	_	_
37-13	4115-4116	O	person[222]	giv[222]	_	_
37-14	4117-4118	(	_	_	_	_
37-15	4119-4122	LLO	abstract	new	coref	38-8
37-16	4123-4124	)	_	_	_	_
37-17	4125-4126	.	_	_	_	_

#Text=Activation of the NF-κB signaling pathway by LLO was reported in the human embryonic kidney HEK-293 cell line , as well as MAPK signaling .
38-1	4127-4137	Activation	abstract[224]	giv[224]	_	_
38-2	4138-4140	of	abstract[224]	giv[224]	_	_
38-3	4141-4144	the	abstract[224]|place[227]	giv[224]|new[227]	coref	43-3[269_227]
38-4	4145-4150	NF-κB	abstract[224]|abstract|place[227]	giv[224]|new|new[227]	coref	43-4
38-5	4151-4160	signaling	abstract[224]|abstract|place[227]	giv[224]|giv|new[227]	coref	38-23[234_0]
38-6	4161-4168	pathway	abstract[224]|place[227]	giv[224]|new[227]	_	_
38-7	4169-4171	by	abstract[224]|place[227]	giv[224]|new[227]	_	_
38-8	4172-4175	LLO	abstract[224]|place[227]|substance	giv[224]|new[227]|giv	ana	39-1
38-9	4176-4179	was	_	_	_	_
38-10	4180-4188	reported	_	_	_	_
38-11	4189-4191	in	_	_	_	_
38-12	4192-4195	the	object[232]	new[232]	_	_
38-13	4196-4201	human	object[232]	new[232]	_	_
38-14	4202-4211	embryonic	object[232]	new[232]	_	_
38-15	4212-4218	kidney	place|object[232]	new|new[232]	_	_
38-16	4219-4226	HEK-293	time|object[232]	new|new[232]	_	_
38-17	4227-4231	cell	place|object[232]	new|new[232]	coref	40-3[239_0]
38-18	4232-4236	line	object[232]	new[232]	_	_
38-19	4237-4238	,	_	_	_	_
38-20	4239-4241	as	_	_	_	_
38-21	4242-4246	well	_	_	_	_
38-22	4247-4249	as	_	_	_	_
38-23	4250-4254	MAPK	abstract|abstract[234]	giv|giv[234]	coref	43-5[0_234]
38-24	4255-4264	signaling	abstract[234]	giv[234]	_	_
38-25	4265-4266	.	_	_	_	_

#Text=It is secreted by L. monocytogenes and promotes the pathogens intracellular survival .
39-1	4267-4269	It	substance	giv	coref	40-14
39-2	4270-4272	is	_	_	_	_
39-3	4273-4281	secreted	_	_	_	_
39-4	4282-4284	by	_	_	_	_
39-5	4285-4287	L.	person	giv	coref	41-2
39-6	4288-4301	monocytogenes	_	_	_	_
39-7	4302-4305	and	_	_	_	_
39-8	4306-4314	promotes	_	_	_	_
39-9	4315-4318	the	substance[237]	giv[237]	_	_
39-10	4319-4328	pathogens	substance[237]	giv[237]	_	_
39-11	4329-4342	intracellular	event[238]	new[238]	_	_
39-12	4343-4351	survival	event[238]	new[238]	_	_
39-13	4352-4353	.	_	_	_	_

#Text=After entering the host cell , lysis of the vacuole is initiated through LLO and the bacterial phospholipases PlcA and PlcB , and followed by intracellular spread in the cytoplasm .
40-1	4354-4359	After	_	_	_	_
40-2	4360-4368	entering	_	_	_	_
40-3	4369-4372	the	place[239]	giv[239]	_	_
40-4	4373-4377	host	place[239]	giv[239]	_	_
40-5	4378-4382	cell	place[239]	giv[239]	_	_
40-6	4383-4384	,	_	_	_	_
40-7	4385-4390	lysis	event[240]	new[240]	_	_
40-8	4391-4393	of	event[240]	new[240]	_	_
40-9	4394-4397	the	event[240]|object[241]	new[240]|new[241]	_	_
40-10	4398-4405	vacuole	event[240]|object[241]	new[240]|new[241]	_	_
40-11	4406-4408	is	_	_	_	_
40-12	4409-4418	initiated	_	_	_	_
40-13	4419-4426	through	_	_	_	_
40-14	4427-4430	LLO	substance	giv	coref	43-15
40-15	4431-4434	and	_	_	_	_
40-16	4435-4438	the	_	_	_	_
40-17	4439-4448	bacterial	_	_	_	_
40-18	4449-4463	phospholipases	abstract|object[244]	new|new[244]	_	_
40-19	4464-4468	PlcA	object[244]	new[244]	_	_
40-20	4469-4472	and	_	_	_	_
40-21	4473-4477	PlcB	abstract	new	_	_
40-22	4478-4479	,	_	_	_	_
40-23	4480-4483	and	_	_	_	_
40-24	4484-4492	followed	_	_	_	_
40-25	4493-4495	by	_	_	_	_
40-26	4496-4509	intracellular	abstract[246]	new[246]	ana	41-13[0_246]
40-27	4510-4516	spread	abstract[246]	new[246]	_	_
40-28	4517-4519	in	abstract[246]	new[246]	_	_
40-29	4520-4523	the	abstract[246]|place[247]	new[246]|new[247]	coref	41-6[250_247]
40-30	4524-4533	cytoplasm	abstract[246]|place[247]	new[246]|new[247]	_	_
40-31	4534-4535	.	_	_	_	_

#Text=Once L. monocytogenes has reached the cytoplasm of the host´s cells , it has been demonstrated to move around and enter neighboring cells using actin comet tails and membrane protrusions to facilitate its spread .
41-1	4536-4540	Once	_	_	_	_
41-2	4541-4543	L.	person|object[249]	giv|giv[249]	_	_
41-3	4544-4557	monocytogenes	object[249]	giv[249]	_	_
41-4	4558-4561	has	_	_	_	_
41-5	4562-4569	reached	_	_	_	_
41-6	4570-4573	the	place[250]	giv[250]	_	_
41-7	4574-4583	cytoplasm	place[250]	giv[250]	_	_
41-8	4584-4586	of	place[250]	giv[250]	_	_
41-9	4587-4590	the	place[250]|place[252]	giv[250]|giv[252]	coref	41-22[254_252]
41-10	4591-4597	host´s	place[250]|place|place[252]	giv[250]|new|giv[252]	_	_
41-11	4598-4603	cells	place[250]|place[252]	giv[250]|giv[252]	_	_
41-12	4604-4605	,	_	_	_	_
41-13	4606-4608	it	abstract	giv	coref	41-33[260_0]
41-14	4609-4612	has	_	_	_	_
41-15	4613-4617	been	_	_	_	_
41-16	4618-4630	demonstrated	_	_	_	_
41-17	4631-4633	to	_	_	_	_
41-18	4634-4638	move	_	_	_	_
41-19	4639-4645	around	_	_	_	_
41-20	4646-4649	and	_	_	_	_
41-21	4650-4655	enter	_	_	_	_
41-22	4656-4667	neighboring	place[254]	giv[254]	_	_
41-23	4668-4673	cells	place[254]	giv[254]	_	_
41-24	4674-4679	using	_	_	_	_
41-25	4680-4685	actin	animal|object[257]	giv|new[257]	_	_
41-26	4686-4691	comet	object|object[257]	new|new[257]	_	_
41-27	4692-4697	tails	object[257]	new[257]	_	_
41-28	4698-4701	and	_	_	_	_
41-29	4702-4710	membrane	object|object[259]	giv|new[259]	_	_
41-30	4711-4722	protrusions	object[259]	new[259]	_	_
41-31	4723-4725	to	_	_	_	_
41-32	4726-4736	facilitate	_	_	_	_
41-33	4737-4740	its	abstract[260]	giv[260]	coref	47-23[292_260]
41-34	4741-4747	spread	abstract[260]	giv[260]	_	_
41-35	4748-4749	.	_	_	_	_

#Text=This F-actin-based intracellular motility is dependent on the expression of another essential listerial virulence factor , ActA .
42-1	4750-4754	This	abstract[261]	new[261]	_	_
42-2	4755-4768	F-actin-based	abstract[261]	new[261]	_	_
42-3	4769-4782	intracellular	abstract[261]	new[261]	_	_
42-4	4783-4791	motility	abstract[261]	new[261]	_	_
42-5	4792-4794	is	_	_	_	_
42-6	4795-4804	dependent	_	_	_	_
42-7	4805-4807	on	_	_	_	_
42-8	4808-4811	the	abstract[262]	new[262]	_	_
42-9	4812-4822	expression	abstract[262]	new[262]	_	_
42-10	4823-4825	of	abstract[262]	new[262]	_	_
42-11	4826-4833	another	abstract[262]|abstract[264]	new[262]|giv[264]	appos	42-17[0_264]
42-12	4834-4843	essential	abstract[262]|abstract[264]	new[262]|giv[264]	_	_
42-13	4844-4853	listerial	abstract[262]|abstract[264]	new[262]|giv[264]	_	_
42-14	4854-4863	virulence	abstract[262]|abstract|abstract[264]	new[262]|giv|giv[264]	_	_
42-15	4864-4870	factor	abstract[262]|abstract[264]	new[262]|giv[264]	_	_
42-16	4871-4872	,	_	_	_	_
42-17	4873-4877	ActA	abstract	giv	_	_
42-18	4878-4879	.	_	_	_	_

#Text=Activation of the NF-κB signaling pathway is , as previously described , achieved through LLO .
43-1	4880-4890	Activation	abstract[266]	new[266]	_	_
43-2	4891-4893	of	abstract[266]	new[266]	_	_
43-3	4894-4897	the	abstract[266]|place[269]	new[266]|giv[269]	_	_
43-4	4898-4903	NF-κB	abstract[266]|abstract|place[269]	new[266]|giv|giv[269]	coref	44-4
43-5	4904-4913	signaling	abstract[266]|abstract|place[269]	new[266]|giv|giv[269]	ana	44-6
43-6	4914-4921	pathway	abstract[266]|place[269]	new[266]|giv[269]	_	_
43-7	4922-4924	is	_	_	_	_
43-8	4925-4926	,	_	_	_	_
43-9	4927-4929	as	_	_	_	_
43-10	4930-4940	previously	_	_	_	_
43-11	4941-4950	described	_	_	_	_
43-12	4951-4952	,	_	_	_	_
43-13	4953-4961	achieved	_	_	_	_
43-14	4962-4969	through	_	_	_	_
43-15	4970-4973	LLO	abstract	giv	_	_
43-16	4974-4975	.	_	_	_	_

#Text=Another mechanism involving NF-κB is its activation by InlC , which is secreted intracellularly .
44-1	4976-4983	Another	abstract[271]	giv[271]	coref	44-6[274_271]
44-2	4984-4993	mechanism	abstract[271]	giv[271]	_	_
44-3	4994-5003	involving	_	_	_	_
44-4	5004-5009	NF-κB	substance	giv	ana	45-1
44-5	5010-5012	is	_	_	_	_
44-6	5013-5016	its	abstract|abstract[274]	giv|giv[274]	coref	46-10[282_274]
44-7	5017-5027	activation	abstract[274]	giv[274]	_	_
44-8	5028-5030	by	abstract[274]	giv[274]	_	_
44-9	5031-5035	InlC	abstract[274]|abstract	giv[274]|new	coref	47-1
44-10	5036-5037	,	_	_	_	_
44-11	5038-5043	which	_	_	_	_
44-12	5044-5046	is	_	_	_	_
44-13	5047-5055	secreted	_	_	_	_
44-14	5056-5071	intracellularly	_	_	_	_
44-15	5072-5073	.	_	_	_	_

#Text=It can directly interact with the subunit of the IκB kinase complex , IKKα .
45-1	5074-5076	It	substance	giv	coref	46-13
45-2	5077-5080	can	_	_	_	_
45-3	5081-5089	directly	_	_	_	_
45-4	5090-5098	interact	_	_	_	_
45-5	5099-5103	with	_	_	_	_
45-6	5104-5107	the	object[277]	new[277]	_	_
45-7	5108-5115	subunit	object[277]	new[277]	_	_
45-8	5116-5118	of	object[277]	new[277]	_	_
45-9	5119-5122	the	object[277]|abstract[278]|object[279]	new[277]|new[278]|giv[279]	coref	46-3[0_278]
45-10	5123-5126	IκB	object[277]|abstract[278]|object[279]	new[277]|new[278]|giv[279]	_	_
45-11	5127-5133	kinase	object[277]|object[279]	new[277]|giv[279]	_	_
45-12	5134-5141	complex	object[277]	new[277]	_	_
45-13	5142-5143	,	_	_	_	_
45-14	5144-5148	IKKα	abstract	new	_	_
45-15	5149-5150	.	_	_	_	_

#Text=By phosphorylating IκB , this complex is critical for the activation of NF-κB , a major regulator of innate immune response .
46-1	5151-5153	By	_	_	_	_
46-2	5154-5169	phosphorylating	_	_	_	_
46-3	5170-5173	IκB	abstract	giv	coref	47-8
46-4	5174-5175	,	_	_	_	_
46-5	5176-5180	this	_	_	_	_
46-6	5181-5188	complex	_	_	_	_
46-7	5189-5191	is	_	_	_	_
46-8	5192-5200	critical	_	_	_	_
46-9	5201-5204	for	_	_	_	_
46-10	5205-5208	the	abstract[282]	giv[282]	_	_
46-11	5209-5219	activation	abstract[282]	giv[282]	_	_
46-12	5220-5222	of	abstract[282]	giv[282]	_	_
46-13	5223-5228	NF-κB	abstract[282]|substance	giv[282]|giv	_	_
46-14	5229-5230	,	_	_	_	_
46-15	5231-5232	a	substance[284]	new[284]	_	_
46-16	5233-5238	major	substance[284]	new[284]	_	_
46-17	5239-5248	regulator	substance[284]	new[284]	_	_
46-18	5249-5251	of	substance[284]	new[284]	_	_
46-19	5252-5258	innate	substance[284]|abstract[286]	new[284]|new[286]	coref	47-13[291_286]
46-20	5259-5265	immune	substance[284]|abstract|abstract[286]	new[284]|new|new[286]	_	_
46-21	5266-5274	response	substance[284]|abstract[286]	new[284]|new[286]	_	_
46-22	5275-5276	.	_	_	_	_

#Text=InlC was shown to impair phosphorylation of IκB , thereby scaling down the hosts immune response , and is also involved in cell-to-cell spread .
47-1	5277-5281	InlC	abstract	giv	_	_
47-2	5282-5285	was	_	_	_	_
47-3	5286-5291	shown	_	_	_	_
47-4	5292-5294	to	_	_	_	_
47-5	5295-5301	impair	_	_	_	_
47-6	5302-5317	phosphorylation	substance[288]	new[288]	_	_
47-7	5318-5320	of	substance[288]	new[288]	_	_
47-8	5321-5324	IκB	substance[288]|object	new[288]|giv	_	_
47-9	5325-5326	,	_	_	_	_
47-10	5327-5334	thereby	_	_	_	_
47-11	5335-5342	scaling	_	_	_	_
47-12	5343-5347	down	_	_	_	_
47-13	5348-5351	the	abstract[291]	giv[291]	_	_
47-14	5352-5357	hosts	person|abstract[291]	new|giv[291]	_	_
47-15	5358-5364	immune	abstract[291]	giv[291]	_	_
47-16	5365-5373	response	abstract[291]	giv[291]	_	_
47-17	5374-5375	,	_	_	_	_
47-18	5376-5379	and	_	_	_	_
47-19	5380-5382	is	_	_	_	_
47-20	5383-5387	also	_	_	_	_
47-21	5388-5396	involved	_	_	_	_
47-22	5397-5399	in	_	_	_	_
47-23	5400-5412	cell-to-cell	abstract[292]	giv[292]	_	_
47-24	5413-5419	spread	abstract[292]	giv[292]	_	_
47-25	5420-5421	.	_	_	_	_
